Zobrazeno 1 - 10
of 93
pro vyhledávání: '"Ihsan, Solaroglu"'
Autor:
Hulya Torun, Buse Bilgin, Muslum Ilgu, Numan Batur, Meric Ozturk, Tayfun Barlas, Gulen Guney-Esken, Cenk Yanik, Suleyman Celik, Ozlem Dogan, Onder Ergonul, Fusun Can, Ihsan Solaroglu, Mehmet C. Onbasli
Publikováno v:
Advanced Devices & Instrumentation, Vol 4 (2023)
Since the discovery of coronavirus disease 2019 (COVID-19) in December 2019, it has been mainly diagnosed with quantitative reverse transcription polymerase chain reaction (PCR) of nasal swabs in clinics. A very sensitive and rapid detection techniqu
Externí odkaz:
https://doaj.org/article/31bd61e80e634526b80f7ef6e5b6bce9
Autor:
Nareg Pinarbasi-Degirmenci, Ilknur Sur-Erdem, Vuslat Akcay, Yasemin Bolukbasi, Ugur Selek, Ihsan Solaroglu, Tugba Bagci-Onder
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 13, p 7051 (2022)
Glioblastoma is the most malignant primary brain tumor, and a cornerstone in its treatment is radiotherapy. However, tumor cells surviving after irradiation indicates treatment failure; therefore, better understanding of the mechanisms regulating rad
Externí odkaz:
https://doaj.org/article/3def9fabfd6846dd85e9e85743a8ec66
Drug Repositioning Screen on a New Primary Cell Line Identifies Potent Therapeutics for Glioblastoma
Autor:
Filiz Senbabaoglu, Ali Cenk Aksu, Ahmet Cingoz, Fidan Seker-Polat, Esra Borklu-Yucel, İhsan Solaroglu, Tugba Bagci-Onder
Publikováno v:
Frontiers in Neuroscience, Vol 14 (2020)
Glioblastoma is a malignant brain cancer with limited treatment options and high mortality rate. While established glioblastoma cell line models provide valuable information, they ultimately lose most primary characteristics of tumors under long-term
Externí odkaz:
https://doaj.org/article/81515be51a0c4324bb5f19fc51784655
Autor:
Ignatius Ngene Esene, Ahmed Negida, Chidiebere S. Ibe, Ulrick S. Kanmounye, Nqobile Thango, Luxwell Jokonya, Samer S. Hoz, Gilbert Dechambenoit, Kazadi K.N. Kalangu, Ihsan Solaroglu
Publikováno v:
World Neurosurgery. 161:265-274
Although randomized interventional studies are the gold standard of clinical study designs, they are not always feasible or necessary. In such cases, observational studies can bring insights into critical questions while minimizing harm and cost. The
Autor:
Alisan Kayabolen, Ugur Akcan, Doğancan Özturan, Hivda Ulbegi‐Polat, Gizem Nur Sahin, Nareg Pinarbasi‐Degirmenci, Canan Bayraktar, Gizem Soyler, Ehsan Sarayloo, Elif Nurtop, Berna Ozer, Gulen Guney‐Esken, Tayfun Barlas, Ismail Selim Yildirim, Ozlem Dogan, Sercin Karahuseyinoglu, Nathan A. Lack, Mehmet Kaya, Cem Albayrak, Fusun Can, Ihsan Solaroglu, Tugba Bagci‐Onder
Publikováno v:
Advanced Science
Soluble ACE2 (sACE2) decoys are promising agents to inhibit SARS-CoV-2, as their efficiency is unlikely to be affected by escape mutations. However, their success is limited by their relatively poor potency. To address this challenge, multimeric sACE
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06b78b2d01572f8bfd0fb1e26e2b1446
http://hdl.handle.net/20.500.12645/30903
http://hdl.handle.net/20.500.12645/30903
Publikováno v:
European Medical Journal Oncology, Iss 1, Pp 91-99 (2014)
The scientific basis for the surgical management of patients with glioma is rapidly evolving. The infiltrative nature of these cancers precludes a surgical cure, but despite this, cytoreductive surgery remains central to high-quality patient’s care
Externí odkaz:
https://doaj.org/article/3e66d89d812843a5819b9fc86f642002
Autor:
Ahmet Cingoz, Tunc Morova, Zeynep H. Gümüş, Tugba Bagci-Onder, Ihsan Solaroglu, Ezgi Ozyerli-Goknar, Fidan Seker-Polat, Myvizhi Esai Selvan, Deepak Bhere, Khalid Shah
Publikováno v:
Oncogene. 40:3201-3216
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces tumor cell-specific apoptosis, making it a prime therapeutic candidate. However, many tumor cells are either innately TRAIL-resistant, or they acquire resistance with adaptive me
Autor:
Murat Korkmaz, Ece Dilege, Selin Ünsaler, Suat Erus, Sukru Dilege, Onder Ergonul, Dursun Bugra, Dogan Vatansever, Burak Giray, Mert Erkan, Ezgi Cesur, Goktug Akyoldas, Ozan Muzaffer Altuntaş, Ihsan Solaroglu, Emre Balik, Ömer Yavuz, Cemil Burak Kulle, Nahit Cakar, Kayhan Tarim, Orhan Bilge, Murat Can Kiremit, Mehdi Sasani, Erdem Canda, Yakup Kordan, Orhan Agcaoglu, Mert Kilic, Talat Kiris, Ibrahim Fethi Azamat, Ozan Gökler, Mehmet Ali Deveci, Serhan Tanju, Ayşenur Meriç Hafiz, Cagatay Taskiran, Aykın Şimşek
Publikováno v:
Journal of Surgical Oncology
Background: we aimed to assess the feasibility and short-term clinical outcomes of surgical procedures for cancer at an institution using a coronavirus disease 2019 (COVID-19)-free surgical pathway during the peak phase of the severe acute respirator
Autor:
Nareg Pinarbasi Degirmenci, Ilknur Sur-Erdem, Vuslat Akcay, Yasemin Bolukbasi, Ugur Selek, Ihsan Solaroglu, Tugba Bagci-Onder
Glioblastoma is the most common type of primary brain tumor with an aggressive clinical course, and one of the cornerstones in its treatment regimen is radiotherapy. However, tumor cells surviving after radiation is an indicator of treatment failure;
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bb1fe9f9924b62fe964a9cf6493360ee
https://doi.org/10.1101/2022.04.16.488495
https://doi.org/10.1101/2022.04.16.488495
Autor:
Hülya Torun, Numan Batur, Buse Bilgin, Omer Tarik Esengur, Kemal Baysal, İbrahim Kulaç, Ihsan Solaroglu, Mehmet Cengiz Onbasli
Publikováno v:
Multiscale Imaging and Spectroscopy III.